To investigate the clinical effects of Shouhui Tongbian Capsule in treating constipation after chemotherapy for hepatobiliary pancreatic malignancy tumors.Methods:A total of 80 cases of elderly hepatobiliary and pancreatic malignant tumor chemotherapy patients admitted to the oncology department of the Second Hospital of Hebei Medical University from August 2016 to August 2018 were selected and randomly divided into an observation group and a control group, with 40 cases in each group according to random number table method.The control group took lactulose oral liquid orally, and the observation group was added to the control group with Shouhui Tongbian Capsule.After continuous treatment for 14 days, the clinical effects of the 2 groups were compared.Results:The clinical efficacy of TCM diseases and syndromes were observed.The total effective rate in the control group reached 75% and the total effective rate in the observation group reached 90%.There was a statistically significant difference between the 2 groups (P<0.05).The clinical symptom score observation showed that the total effective rate of the control group reached 77.5% and the total effective rate of the observation group reached 92.5%.There was a statistically significant difference between the 2 groups (P<0.05).The defecation score (VAS score) was observed.After treatment, the defecation interval of the control group was reduced to (2.87±0.77) d, which was higher than that of the observation group(2.02±0.54) d.The defecation time of the control group was (11.37±2.83) min, which was longer than the observation group (7.25±2.25) min.The VAS score showed that the differences between the 2 groups were statistically significant (P<0.05).Conclusion:Shouhui Tongbian Capsule can effectively prevent constipation after chemotherapy of hepatobiliary and pancreatic malignant tumors, effectively alleviate the degree of defecation pain and reduce the time of defecation.